LakeShore Biopharma Co., Ltd. (LSBCF): key financial figures for fiscal year 2024 (in CNY), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024): ¥615.0M
Net Income/Loss (FY2024): -¥100.0M
Total Assets (FY2024): ¥1.4B
Total Equity (FY2024): ¥499.8M
Cash Flows from Operating Activities (FY2024): -¥121.0M

Source: LakeShore Biopharma Co., Ltd. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

LakeShore Biopharma Co., Ltd. (LSBCF): key financial figures for fiscal year 2024 (in CNY), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024): ¥615.0M
Net Income/Loss (FY2024): -¥100.0M
Total Assets (FY2024): ¥1.4B
Total Equity (FY2024): ¥499.8M
Cash Flows from Operating Activities (FY2024): -¥121.0M

Source: LakeShore Biopharma Co., Ltd. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.